PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11501956

Prothrombotic genetic markers.

M L Rossi·P A Merlini·D Ardissino
View original source ↗Export metadata ↓

Abstract

The last decade has been characterized by an explosion of research studies on genetic epidemiology. In particular, as far as ischemic heart disease is concerned, a lot of research was focused on prothrombotic genetic risk factors. Unfortunately, the success of this approach in the field of venous thrombosis has not been replicated in the field of myocardial infarction. In the present editorial, a comment on the studies already available is provided and the possible limitations of the present approach are analyzed.

Explore related subjects

Coronary ThrombosisFactor VIIFibrinogenGenetic MarkersHumansMutationPlatelet Glycoprotein GPIIb-IIIa ComplexProthrombinRisk FactorsEditorial

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M L Rossi, P A Merlini, D Ardissino. 2001. Prothrombotic genetic markers.. https://pubmed.ncbi.nlm.nih.gov/11501956/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Two- and three-dimensional echocardiographic imaging of massive left intraventricular thrombosis complicating fatal heart failure.

These images describe a case of massive left ventricular (LV) thrombosis complicating fatal heart failure in a 61 year-old patient with history of myocardial infarction, apical aneurysm, and no previous evidence of LV thrombosis. Two-dimensional echocardiography showed that the thrombus obliterated 34% of LV volume at end-diastole. Three-dimensional echocardiography allowed higher definition of thrombus architecture and dimensions, revealing obliteration of 40% of LV volume at end-diastole. Careful assessment of thromboembolic risk to guide therapeutic decision making should be considered mandatory in subjects with a large extent of wall asynergy, even in those with no previous evidence of LV thrombosis. Three-dimensional echocardiography may be considered an accurate technique for the characterization of LV thrombi in these patients.

Coronary Thrombosis↗
PubMed2006

Simultaneous multivessel acute drug-eluting stent thrombosis.

Stent thrombosis (ST) in the era of bare metal stents (BMS) using high-pressure stent deployment and combined anti-platelet therapy is an uncommon but feared complication. There is concern for an elevated risk of stent thrombosis (ST) with drug-eluting stents (DES). We describe a case of simultaneous multivessel drug-eluting stent thrombosis 8 h after deployment of paclitaxel-eluting stents in the right coronary (RCA) and left anterior descending (LAD) arteries.

Coronary Thrombosis↗